Volume Alert - TWTR 41.05 Twitter Inc $TWTR Hit a high

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - TWTR 41.05 Twitter Inc $TWTR Hit a high today of 41.17 Closing the day 10:30 at 41.05 +0.58 +1.43% With a day low of 40.65 and a total volume of 4,127,702.

TWTR Recent Posts: http://investorshangout.com/Twitter-Inc-TWTR-88434/

TWTR Twitter Inc Recent Headline News

Why a Music Streaming Service Makes No Sense for Twitter
Adam Levy, The Motley Fool - Motley Fool - 2 hrs 35 mins ago
Twitter CFO Anthony Noto, who joined the company in July, thinks he knows why Twitter's attempt at a music streaming service failed in less than a year. He also made a point that Twitter will never offer its own music streaming service again. ...
FB: 74.15 (-0.09), TWTR: 40.37 (-0.10)

Unbundling strategy Could Drive Facebook valuation
Virendra Singh Chauhan - Amigobulls - 2 hrs 52 mins ago
Effective monetization of Facebook properties could drive Facebook revenue growth and Valuation, positioning Facebook strongly in the social media space
FB: 74.15 (-0.09), TWTR: 40.37 (-0.10)

'Fast Money' Recap: Stay Short the Yen Following Japan's GDP Miss
at The Street - Tue Nov 18, 4:00AM CST
The trading panel discussed Japan's surprising announcement and whether Twitter is a better bet than Facebook or LinkedIn.
CST: 42.92 (+1.01), AMZN: 327.47 (+4.42), GE: 26.90 (+0.29), FB: 74.15 (-0.09), HAL: 49.51 (+0.28), WMT: 83.60 (+0.03), TLT: 119.46 (+0.27), SLB: 96.03 (+0.40), LNKD: 224.40 (+1.12), SUNE: 20.59 (+3.98), TGT: 66.63 (-0.50), CVS: 90.29 (+0.17), GOOGL: 549.59 (+2.95), TWTR: 40.37 (-0.10), GDX: 19.86 (+0.47), BHI: 65.66 (+0.43)

Most active New York Stock Exchange-traded stocks
AP - Mon Nov 17, 5:02PM CST
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:
KMI: 40.53 (+0.28), GE: 26.90 (+0.29), F: 15.38 (-0.16), PFE: 30.58 (+0.26), HAL: 49.51 (+0.28), EMC: 30.59 (+0.21), BAC: 17.20 (+0.11), DNR: 9.93 (-0.08), TWTR: 40.37 (-0.10), BHI: 65.66 (+0.43)

Do Not Short Twitter Stock
Kofi Bofah - at Seeking Alpha - Mon Nov 17, 4:54PM CST

TWTR: 40.36 (-0.11)

Is Google Glass Losing Its Sheen Already? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 2:50PM CST
While Google Inc. (GOOGL) remains enthusiastic about its groundbreaking Google Glass technology, some app developers have already started to lose interest.
BIDU: 242.82 (-1.33), XWES: 5.45 (-0.01), GOOGL: 549.59 (+2.95), TWTR: 40.36 (-0.11), MELI: 134.65 (+0.94)

Twitter's Bar Mitzvah! Is Social Media Coming Of Age?
Aswath Damodaran - at Seeking Alpha - Mon Nov 17, 2:38PM CST
Life's transitions, from single to married , from renter to homeowner, and from employed to retired, just to name a few, are never easy, since the rules change, as do the measures of success and failure and that is perhaps the reason that they are...
TWTR: 40.37 (-0.10)

A Foolish Take on Twitter's Analyst Day Marathon
Jason Moser, The Motley Fool - Motley Fool - Mon Nov 17, 2:30PM CST
My goal in going through the 111 page transcript from Twitter's recent analyst day was to learn more about Twitter the business and management's strategies for the coming years. It was not to write down every single note of everything that was...
TWTR: 40.37 (-0.10)

Twitter Debt Gets Junk Rating: Should You Worry? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 2:22PM CST
Twitter's (TWTR) optimistic outlook regarding the long-term strategy seems to be only a flash in the pan outweighed by Standard and Poor Junk level rating for its debt.
YHOO: 51.73 (-0.64), FB: 74.15 (-0.09), GOOGL: 549.59 (+2.95), TWTR: 40.37 (-0.10)

Jim Cramer Answers Twitter (TWTR) Questions on Gold, Gilead and More
at The Street - Mon Nov 17, 1:53PM CST
TheStreet's Jim Cramer answers Twitter (TWTR) questions on gold, Gilead (GILD), energy stocks and more.
JNJ: 108.97 (+0.67), GILD: 101.94 (+1.50), GLD: 114.96 (+0.91), ABBV: 65.70 (+0.66), TWTR: 40.37 (-0.10), NVS: 95.64 (+1.26)

Twitter (TWTR) Stock Falls After S&P's Junk-Level Credit Rating
at The Street - Mon Nov 17, 11:57AM CST
Shares of Twitter (TWTR) continue to decline Monday after Standard & Poor's labeled Twitter with a junk-level credit rating late last week.
TWTR: 40.37 (-0.10)

Technology Stock Roundup: Cisco Reports/Yahoo Buys BrightRoll - Analyst Blog
Sejuti Banerjea - Zacks Investment Research - Mon Nov 17, 9:54AM CST
Last week was highly eventful for the technology sector with the earnings announcement from Cisco (CSCO), new products from Apple (AAPL), Google (GOOGL), Amazon (AMZN), acquisitions by Yahoo (YHOO) and Microsoft (MSFT) and more.
AMZN: 327.47 (+4.42), FB: 74.15 (-0.09), GOOGL: 549.59 (+2.95), TWTR: 40.37 (-0.10), MSFT: 48.90 (-0.56), AAPL: 114.41 (+0.42), CSCO: 26.63 (+0.16)

Why Twitter is Down Nearly 20% Over the Past Month
Evan Niu, CFA, The Motley Fool - Motley Fool - Mon Nov 17, 9:17AM CST
Over the past month, shares of Twitter have lost 17% of their value. Obviously, that can't be fun for the microblogger's investors. Let's look at what's driving the decline, and whether there is light at the end of the tunnel. Twitter's...
FB: 74.15 (-0.09), TWTR: 40.37 (-0.10)

Twitter Debt Rated Junk, What About The Stock?
Vikram Nagarkar - Amigobulls - Mon Nov 17, 8:37AM CST
S&P assigned Twitter debt with a junk rating. The rating raises questions about Twitter’s stock rating. Twitter valuations make it a risky bet.
FB: 74.15 (-0.09), TWTR: 40.37 (-0.10)

Kim Kardashian Didn't Break the Internet, But She Did Set a New Benchmark
at The Street - Mon Nov 17, 8:21AM CST
After posing nude for Paper magazine and taunting haters, the reality television star can say she upped the ante on the social media stunt. Internet, it's your move now.
FB: 74.15 (-0.09), TWTR: 40.37 (-0.10), GLUU: 3.87 (+0.10)

Insider Trading Alerts for Tesla, Globalstar, Boston Scientific, Apple, Yahoo, and Twitter
PR Newswire - Mon Nov 17, 7:45AM CST
Pennystocksinsiders.com (PSI) released FREE insider trading reports for US market investors to track the following active stocks and penny stocks: Tesla (NASDAQ:TSLA), Globalstar (NYSEMKT:GSAT), Boston Scientific (NYSE:BSX), Apple (NASDAQ:AAPL), Yahoo! (NASDAQ:YHOO), and Plug Power (NASDAQ LUG).
BSX: 13.45 (+0.07), YHOO: 51.73 (-0.64), TSLA: 258.22 (+4.24), PLUG: 3.97 (+0.25), TWTR: 40.37 (-0.10), AAPL: 114.41 (+0.42), GSAT: 2.58 (-0.22)

Solid Confidence Numbers; Ocwen Signposts; Shorting QQQ: Best of Kass
at The Street - Sun Nov 16, 3:59PM CST
In highlights from his trading diary of the past week, Doug Kass discusses consumer confidence, Ocwen's unsettled deal with Wells Fargo and why he's shorting the Nasdaq.
NFLX: 382.98 (+1.84), AMZN: 327.47 (+4.42), QQQ: 103.41 (+0.50), EBAY: 55.00 (+0.17), OCN: 21.17 (+0.02), FB: 74.15 (-0.09), WFC: 53.45 (+0.01), GOOGL: 549.59 (+2.95), FDN: 61.69 (+0.16), TWTR: 40.37 (-0.10), PCLN: 1,161.74 (-4.67), BABA: 111.68 (-2.57)

Notes From Twitter's Investor Day: Execution Remains The Key
WestEnd511 - at Seeking Alpha - Sat Nov 15, 9:44PM CST

FB: 74.15 (-0.09), TWTR: 40.36 (-0.11)

Twitter Has A Compelling Ten-Year Growth Trajectory
Alex Cho - at Seeking Alpha - Sat Nov 15, 3:56PM CST

FB: 74.14 (-0.10), TWTR: 40.36 (-0.11)

Twitter Inc. (TWTR) Stock Research Links

TWTR Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PPL Reports Strong Q3; Long-Term EPS Growth Up

Updated Category News Views 29

Solid Earnings in a Challenging Market Anytime you start hearing a company like PPL boasting about their quarterly earnings, it's time to sit up straight and pay attention. The utility giant didn’t just match expectations, they beat 'em, clocking in with $0.54 per share in ongoing earnings for Q3 2026, up from $0.48 the previous year. Not a bad step forward if you ask...

Continue Reading
Thryfter Unleashes Livestream Magic at Goodwill Event

Updated Category News Views 89

A Dynamic Shift in Thrift Shopping All eyes might be on Thryfter this November as they drop some serious retail knowledge at the Goodwill CONNECT Conference in Houston. We’re talking about a tech shake-up for Goodwill’s model, thanks to Thryfter's livestream shopping craze that’s poised to weld traditional thrifting with digital reach. The Power of Virtual Thrift...

Continue Reading
RCMA Makeup Makes Bold Retail Move with Ulta.com Debut

Updated Category News Views 25

RCMA Makeup: A Longstanding Industry Insider You know when a brand’s been around the block since the 60s, it’s got staying power. RCMA Makeup’s been a snug fit in the toolbox of professional makeup artists for over six decades. This ain't some fly-by-night operation. They’ve thrived on word of mouth—no flashy ads or promotional stunts. Just rock-solid reputation...

Continue Reading
Encompass Health Faces Uncertain Future with Sea Pines

Updated Category News Views 68

Unexpected Downpour Closes Sea Pines They say when it rains, it pours. That's not just true in life, but as it happens, it's quite literal in Melbourne, Florida. A deluge of biblical proportions forced an immediate lockdown of the Sea Pines Rehabilitation Hospital. Flooded to the gills, this once stalwart institution finds its doors shuttered indefinitely. It's a...

Continue Reading
Home Insurance Depreciation and What it Means for You

Updated Category News Views 17

A Deep Dive into Depreciation's Impact on Home Insurance Folks, if you haven't battled the insurance beast, you're missing out on an unholy mess. Let's talk about something that's been quietly gnawing at homeowners’ wallets—depreciation in home insurance claims. Peggy Schneider, an insurance guru from Kalispell, Montana, lays it all out in HelloNation, and I'm here to...

Continue Reading
CMS 2027 Fee Schedule: Game Changer for SI Joint Procedures

Updated Category News Views 145

CMS's Move: A New Payment Pathway You don't expect bureaucrats to stir things up, but check this out: the CMS 2027 Physician Fee Schedule has done just that by setting a non-facility (office) payment rate for CPT code 27279. This code covers those fiddly, minimally invasive sacroiliac (SI) joint procedures, where you engage bone and get down to real orthopedic business....

Continue Reading
Koozee Boosts Apparel Design with AI Workflows

Updated Category News Views 108

Revolutionizing Apparel Design with AI If you've ever wondered how tech can make an impact on the fashion world, Koozee's latest update provides an eye-opening look. This isn't about following trends—it's about setting them, and Koozee’s making a bold move with its newest platform enhancements. Introducing Freeform Canvas Koozee has launched the Freeform Canvas, a...

Continue Reading
Strategies for Maintaining Water Quality in NH Homes

Updated Category News Views 92

Protect Your Water: Steps to Safe Drinking Imagine turning on your kitchen tap, and instead of refreshing, clean water, you get a murky mystery. Not exactly anyone's dream scenario, right? Enter Sean McGorry and his down-to-earth guide to water quality for New Hampshire homesteaders. It's not rocket science, but the whispers of neglected water systems tell tales of...

Continue Reading
Upright Proton Therapy: New Era for Cancer Care

Updated Category News Views 129

BayCare's Bold Step into Upright Proton Therapy Here's a twist for you—BayCare Health System has rolled out something that's genuinely pushing the envelope in cancer treatment. They've treated their first patient with an upright proton therapy system. Now, talk about innovation that shakes things up. This isn't just any old upgrade; it's a complete revamp of how proton...

Continue Reading
SM Investments Wins Five Golden Arrows: Governance on Point

Updated Category News Views 82

Gold Arrows and Golden Standards What’s in a bunch of gold arrows, you might ask? Well, for SM Investments Corporation, those Five Golden Arrows from the Institute of Corporate Directors aren't just shiny trinkets. They're badges of honor, symbols of a rock-solid governance fortress. For the third year running, they’ve nailed the top spot under the corporate...

Continue Reading

Top 5 Most Recently Viewed Articles

Yale School of Medicine Celebrates Achievements in Research

Updated Category News Views 167

Yale School of Medicine Celebrates Achievements in Research Today, twenty-seven distinguished faculty members from Yale School of Medicine (YSM) were honored for their remarkable contributions to the field of medical research. Recognized as Highly Cited Researchers for the year 2025, these experts are acknowledged for their influential studies that have garnered...

Continue Reading
Saothair Capital Partners Strengthens Portfolio with T BAILEY

Updated Category News Views 399

Saothair Capital Partners Acquires Majority Stake in T BAILEY In a strategic move, Saothair Capital Partners, LLC has completed the acquisition of a majority equity stake in T BAILEY, LLC. This acquisition signals Saothair's commitment to investing in the middle-market manufacturing sector. Known for its extensive experience and focus, Saothair aims to enhance T BAILEY's...

Continue Reading
Semtech's Earnings Report: What to Anticipate This Quarter

Updated Category News Views 114

Semtech's Earnings Report: What Investors Should Expect Semtech (NASDAQ: SMTC) is gearing up to release its latest quarterly earnings report shortly. As anticipation builds, it's crucial for investors to stay informed on what this means for their holdings in the company. Analysts have projected that Semtech will deliver an earnings per share (EPS) of $0.23. Investors are...

Continue Reading
Vistra Energy Faces Challenges After Battery Facility Fire

Updated Category News Views 192

Vistra Energy Stock Takes a Hit Due to Facility Incident Shares of Vistra Energy (NYSE: VST) experienced a decline of 1.4% in early trading today, following reports of a significant fire at a battery facility located at the company’s Moss Landing power plant. This facility, situated in Monterey County, was put into emergency lockdown as authorities evacuated surrounding...

Continue Reading
Compass Therapeutics Elevates Growth with $120 Million Offering

Updated Category News Views 186

Compass Therapeutics Unveils Significant Public Offering Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a dedicated clinical-stage biopharmaceutical company focused on oncology, has excitedly announced the pricing of an upsized public offering. This offering includes 33,290,000 shares of common stock priced at $3.00 each, along with pre-funded warrants for...

Continue Reading